MARKETS

LiveTV

Gold Rate

Fresenius Kabi Oncology Ltd.

BSE: 532545 | NSE: FKONCO | Series: NA | ISIN: INE575G01010 | SECTOR: PharmaceuticalsPharmaceuticals

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Fresenius Kabi Fresenius Kabi Oncology Ltd. | BSE 132.45 0.00 (0.00%) | NSE 1035.00 902.50 (681.13%) | Trade | Add

BSE Live

Jan 02, 15:50

132.45 0.00 (0.00%)

Volume

No Data Available

Prev. Close

132.45
Open Price

132.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
132.45 (20430)

Fresenius Kabi Oncology is not traded on BSE in the last 30 days

NSE Live

Oct 13, 12:27

1035.00 902.50 (681.13%)

Volume

No Data Available

Prev. Close

132.50
Open Price

1030.60

Bid Price (Qty.)
1033.80 (729)
Offer Price (Qty.)
1035.87 (652)

Fresenius Kabi Oncology is not traded on NSE in the last 30 days

Financials

Print/Copy to Excel : Go

Data Not Available for Cash Flow

Results of Fresenius Kabi

29.03.2016

India Inc's Feb foreign borrowing down 40% at &#36;1.35 bn
03.03.2014

AstraZeneca delisting: Time for Sebi to amend guidelines?
11.02.2014

Fresenius Kabi standalone Dec '13 sales at Rs 84.66 crore
04.02.2014

Stocks in news: Sterling Holidays, Power Grid, Tata Chem

11.02.2014

Fresenius Kabi standalone Dec '13 sales at Rs 84.66 crore
25.10.2013

Fresenius Kabi standalone Sep '13 sales at Rs 96.15 crore
12.08.2013

Fresenius Kabi standalone Jun '13 sales at Rs 126.87 crore
13.02.2013

Fresenius Kabi standalone Dec '12 sales at Rs 205.04 crore

01.01.1970

01.01.1970

Results of Pharmaceuticals Sector

22.07.2021

Gland Pharma’s new product play for FY22 holds a lot of promise
15.11.2017

Hold Indoco Remedies; target of Rs 250: ICICI Direct
05.10.2017

Buy Natco Pharma; target of Rs 1065: ICICI Direct
18.07.2017

Cipla Q1 PAT may dip 46.52% YoY to Rs 199.6 cr: KR Choksey

28.02.2017

Sanofi India Q4 net declines 58% to Rs 50.5 cr
27.02.2017

Merck Dec-qtr net up 25% at Rs 18 cr
14.02.2017

Claris Lifesciences net profit up 233 pc at Rs 35 cr in Q3
14.02.2017

Sun Pharma Q3 profit dragged by slowdown in US & India sales

18.07.2017

Cipla Q1 PAT may dip 46.52% YoY to Rs 199.6 cr: KR Choksey
13.02.2017

Sun Pharma Q3 profit seen up 27%; US & India biz may grow 10%
09.02.2017

Aurobindo Q3 profit seen up 14%, revenue may grow 10% on US biz
09.02.2017

Lupin Q3 profit seen up 15% to Rs 609cr, US biz may lift revenue

15.02.2017

Ranbaxy deal to kick in, Halol overhang on Sun Pharma:Brokerages
06.02.2017

Good Q3 but Dr Reddy's still far from sustainable growth: Expert
10.11.2016

Sun Pharma Q2 show healthy but margins unsustainable: Nangra
09.11.2016

Low earnings for Lupin to continue for next 2 qtrs: IIFL

Fresenius Kabi Oncology Ltd.

Financials

Results of Fresenius Kabi

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches